Literature DB >> 22479065

Stability of cefazolin sodium in polypropylene syringes and polyvinylchloride minibags.

Ronald F Donnelly1.   

Abstract

BACKGROUND: Cefazolin is a semisynthetic penicillin derivative with a narrow spectrum of activity covering some gram-positive organisms and a few gram-negative aerobic bacteria.
OBJECTIVE: To determine the physical and chemical stability of cefazolin sodium reconstituted with sterile water for injection and stored in polypropylene syringes or diluted with either 5% dextrose in water (D5W) or 0.9% sodium chloride (normal saline [NS]) and stored in polyvinylchloride (PVC) minibags.
METHODS: Reconstituted solutions of cefazolin (100 or 200 mg/mL) were packaged in polypropylene syringes. More dilute solutions (20 or 40 mg/mL) were prepared in D5W or NS and packaged in PVC minibags. For each concentration-diluent-container combination, 3 containers were designated for each day of analysis (days 7, 14, 21, and 30). Containers were stored under refrigeration (5°C) with protection from light until the designated day of analysis, at which time one 5-mL sample was collected from each the designated container. The designated containers were then stored at room temperature (21°C to 25°C) with exposure to light for an additional 72 h, and additional samples were drawn. The samples were assayed using a validated, stability-indicating high-performance liquid chromatography method. The colour and clarity of the solutions, as well as their pH, were also monitored on each sampling day.
RESULTS: All samples remained clear for the duration of the study; they had a slight yellow colour that darkened over time, and there was an increase in pH. Solutions diluted with sterile water for injection and stored in polypropylene syringes retained at least 94.5% of the initial concentration after 30 days of refrigerated storage and at least 92.1% after an additional 72 h at room temperature with exposure to light. Samples diluted in D5W or NS and stored in PVC minibags retained at least 95.8% of the initial concentration after 30 days of refrigerated storage and at least 91.8% after an additional 72 h at room temperature with exposure to light.
CONCLUSIONS: Cefazolin at various concentrations stored in polypropylene syringes or PVC minibags was stable for up to 30 days with storage at 5°C with protection from light, followed by an additional 72 h at 21°C to 25°C with exposure to light.

Entities:  

Year:  2011        PMID: 22479065      PMCID: PMC3161797          DOI: 10.4212/cjhp.v64i4.1035

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  5 in total

1.  Comparative stability of antibiotic admixtures in minibags and minibottles.

Authors:  B A Dinel; D L Ayotte; R J Behme; B L Black; J L Whitby
Journal:  Drug Intell Clin Pharm       Date:  1977-04

2.  Activity of antibiotic admixtures subjected to different freeze-thaw treatments.

Authors:  C J Holmes; R K Ausman; C W Walter; R B Kundsin
Journal:  Drug Intell Clin Pharm       Date:  1980-05

3.  Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.

Authors:  Vishnu D Gupta
Journal:  Int J Pharm Compd       Date:  2003 Mar-Apr

4.  Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions.

Authors:  L M Galanti; J D Hecq; D Vanbeckbergen; J Jamart
Journal:  J Clin Pharm Ther       Date:  1996-06       Impact factor: 2.512

5.  Quantitation of carbenicillin disodium, cefazolin sodium, cephalothin sodium, nafcillin sodium, and ticarcillin disodium by high-pressure liquid chromatography.

Authors:  V D Gupta; K R Stewart
Journal:  J Pharm Sci       Date:  1980-11       Impact factor: 3.534

  5 in total
  4 in total

1.  Intravenous Push Administration of Antibiotics: Literature and Considerations.

Authors:  Samantha Spencer; Heather Ipema; Patricia Hartke; Courtney Krueger; Ryan Rodriguez; Alan E Gross; Michael Gabay
Journal:  Hosp Pharm       Date:  2018-03-08

2.  Isolation and characterisation of degradation impurities in the cefazolin sodium drug substance.

Authors:  Balasubramanian Sivakumar; Kannabiran Parthasarathy; Raman Murugan; Ramajeyabalan Jeyasudha; Saravanan Murugan; Rajendira Janardhan Saranghdar
Journal:  Sci Pharm       Date:  2013-06-04

3.  Recovery of cefazolin and clindamycin in in vitro pediatric CPB systems.

Authors:  Gerdien A Zeilmaker-Roest; Annewil van Saet; Marloes P J van Hoeven; Birgit C P Koch; Joost van Rosmalen; Martina Kinzig; Fritz Söergel; Enno D Wildschut; Robert J Stolker; Dick Tibboel; Ad J J C Bogers
Journal:  Artif Organs       Date:  2020-01-06       Impact factor: 3.094

4.  Stability and Compatibility Aspects of Drugs: The Case of Selected Cephalosporins.

Authors:  Szymon Tomczak; Aleksandra Gostyńska; Malwina Nadolna; Karolina Reisner; Marta Orlando; Anna Jelińska; Maciej Stawny
Journal:  Antibiotics (Basel)       Date:  2021-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.